The weekly litigation news digest is live. Subscribe now

IP Verse

Subcutaneous Formulations Of Anti-Cd38 Antibodies And Their Uses - EP3827845

The patent EP3827845 was granted to Janssen Biotech on Mar 30, 2022. The application was filed on Nov 1, 2016 under application number EP20215879A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3827845

JANSSEN BIOTECH
Application Number
EP20215879A
Filing Date
Nov 1, 2016
Status
Granted And Under Opposition
Feb 25, 2022
Publication Date
Mar 30, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
STORZDec 29, 2022MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBBADMISSIBLE
PATENT BOUTIQUEDec 29, 2022PATENT BOUTIQUEWITHDRAWN
KONIG SZYNKA TILMANN VON RENESSEDec 27, 2022KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORFADMISSIBLE
DR H ULRICH DORRIESDec 22, 2022DORRIESADMISSIBLE
DR H ULRICH DORRIESDec 22, 2022DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMANADMISSIBLE
XBRANE BIOPHARMADec 21, 2022YILDIRIMADMISSIBLE

Patent Citations (75) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2007287170
DESCRIPTIONUS2009182127
DESCRIPTIONUS2010015133
DESCRIPTIONUS2010286374
DESCRIPTIONUS2011123532
DESCRIPTIONUS2012149876
DESCRIPTIONUS4683195
DESCRIPTIONUS5223409
DESCRIPTIONUS5403484
DESCRIPTIONUS5427908
DESCRIPTIONUS5571698
DESCRIPTIONUS5580717
DESCRIPTIONUS5885793
DESCRIPTIONUS5932448
DESCRIPTIONUS5969108
DESCRIPTIONUS6172197
DESCRIPTIONUS6521404
DESCRIPTIONUS6544731
DESCRIPTIONUS6555313
DESCRIPTIONUS6582915
DESCRIPTIONUS6593081
DESCRIPTIONUS6737056
DESCRIPTIONUS6833441
DESCRIPTIONUS7695936
DESCRIPTIONUS7767429
DESCRIPTIONUS7829693
DESCRIPTIONUS8088896
DESCRIPTIONUS8153765
DESCRIPTIONWO2004078140
DESCRIPTIONWO2004111233
DESCRIPTIONWO2005103083
DESCRIPTIONWO2006125640
DESCRIPTIONWO2007042309
DESCRIPTIONWO2008047242
DESCRIPTIONWO2008077546
DESCRIPTIONWO2008119353
DESCRIPTIONWO2009085462
DESCRIPTIONWO2009134776
DESCRIPTIONWO2011131746
DESCRIPTIONWO2011143545
DESCRIPTIONWO2012022811
DESCRIPTIONWO2014178820
DESCRIPTIONWO8801649
DESCRIPTIONWO9201047
DESCRIPTIONWO9413804
DESCRIPTIONWO9844001
OPPOSITIONAU2013200711
OPPOSITIONEP2459167
OPPOSITIONEP2477603
OPPOSITIONEP3370770
OPPOSITIONUS2010074885
OPPOSITIONUS2011053247
OPPOSITIONUS2011066111
OPPOSITIONUS2011076273
OPPOSITIONUS2013022588
OPPOSITIONUS2015118251
OPPOSITIONUS2015231235
OPPOSITIONUS250016
OPPOSITIONUS8318154
OPPOSITIONWO2004078140
OPPOSITIONWO2007005608
OPPOSITIONWO2008037257
OPPOSITIONWO2008150949
OPPOSITIONWO2010087972
OPPOSITIONWO2010102251
OPPOSITIONWO2011012637
OPPOSITIONWO2011029892
OPPOSITIONWO2012064627
OPPOSITIONWO2013102144
OPPOSITIONWO2014105810
OPPOSITIONWO2015100366
OPPOSITIONWO2016187546
OPPOSITIONWO2016209921
OPPOSITIONWO2017079150
SEARCHUS2015118251

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents